Letters The truth about Tamiflu?

Data access is matter of trust

BMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c134 (Published 13 January 2010) Cite this as: BMJ 2010;340:c134
  1. Alan R Maryon-Davis, president1
  1. 1UK Faculty of Public Health, London NW1 4LB
  1. president{at}fph.org.uk

    The UK Faculty of Public Health strongly supports the BMJ’s call for mandatory disclosure of raw data of all trials cited in drug licensing applications and …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial